Ciox Secures Equity Investment from Merck Global Health Innovation Fund
Summary
Ciox rapidly and securely facilitates access to clinical records on behalf of its healthcare provider customers, enabling increased data liquidity and the improvement of health care outcomes. In this newly announced relationship, Ciox is continuing to enhance its core capability of providing clinical data liquidity to reduce healthcare costs and improve the quality of patient outcomes. “We are pleased to partner with Ciox, a leader in moving data and information among provider systems, patients and clients,” added David M. Rubin, Ph.D., and Managing Director of Merck GHIF. “Ciox brings a unique approach to accessing real world data at scale, and we expect them to partner intimately with companies within the GHI oncology digital health portfolio. With a vision that data will be the currency in healthcare, MGHIF invests primarily in core areas of interest to Merck including oncology, infectious disease, diabetes, vaccines and hospital acute care.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
